Characteristic | OR (95% CI) | P-Value |
---|---|---|
Age | 1.10 (1.04–1.17) | < 0.001* |
Gender | 1.14 (0.47–2.75) | 0.773 |
BMI | 1.08 (0.99–1.16) | 0.078 |
Group | 1.00 (0.45–2.21) | 0.996 |
Diagnosis Duration | 0.88 (0.64–1.20) | 0.417 |
Symptom Duration | 0.94 (0.78–1.14) | 0.541 |
Education (Years) | 0.93 (0.83–1.04) | 0.214 |
Total Medications | 1.07 (0.91–1.25) | 0.421 |
Antidepressant Use | 1.53 (0.69–3.41) | 0.298 |
Benzodiazepine Use | 0.36 (0.07–1.60) | 0.178 |
Total Comorbidities | 1.10 (0.93–1.31) | 0.270 |
Diabetes | 0.96 (0.30–3.11) | 0.951 |
Hypertension | 1.76 (0.77–3.98) | 0.179 |
Arthritis | 0.86 (0.23–3.20) | 0.820 |
Baseline ADAS-Cog | 1.05 (1.01–1.09) | 0.025* |
Baseline CDR-Sb | 1.19 (0.98–1.45) | 0.081 |